7774 fundamentals

Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. It operates through the following segments: Regenerative Medicine Product Business, Regenerative Medicine Contract Business and Research and Development Support Business. The Regenerative Medicine Product Business segment manufactures and sells autologous cultured epidermis (JACE) and autologous cultured cartilage (JACK), among other products. The Regenerative Medicine Contract Business segment specializes in developing and manufacturing regenerative medicine products, supporting clinical development, providing regulatory consulting, and contract manufacturing specific cell products. The Research and Development Support Business manufactures and sells human cultured tissue for research applying advanced cell culture technology. The company was founded on February 1, 1999 and is headquartered in Gamagori, Japan.